Foot News and Research

RSS

Ortho Biotech submits NDA for Trabectedin in relapsed ovarian cancer

Ortho Biotech Products, L.P. has announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL (doxorubicin HCI liposome injection) for the treatment of women with relapsed ovarian cancer (ROC).

20 Nov 2008

Preventing ingrown toenails in children

Parents can help prevent a common and painful foot problem in children by following a few simple tips, according to the American College of Foot and Ankle Surgeons (ACFAS).

18 Nov 2008

Object-tracking exercises train athlete brains to react faster

All great athletes know that in order to perform well, they can't just depend on their physical capabilities.

18 Nov 2008

Discovery of new mechanism that regulates formation of blood vessels

Researchers in one of the external groups of the Instituto Gulbenkian de Ciencia (IGC), in Portugal, have discovered a novel mechanism which regulates the process whereby new blood vessels are formed and wounds heal, including chronic wounds, such as those found in diabetic patients and those suffering from morbid obesity.

17 Nov 2008

Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections

Swissmedic, the Swiss agency for therapeutic products, has approved Zevtera (ceftobiprole medocaril) for the treatment of complicated skin and soft tissue infections, including diabetic foot infections which have not spread to the bone.

13 Nov 2008

Diabetes and foot problems

Bradford Miller has had diabetes for nine years, and he knows the importance of quick treatment for related problems such as swelling and numbness in the feet.

11 Nov 2008

Further evidence that angiogenesis drugs can be much more effective when combined with chemotherapy

Scientists have thought that one way to foil a tumor from generating blood vessels to feed its growth - a process called angiogenesis - was by creating drugs aimed at stopping a key vessel growth-promoting protein.

10 Nov 2008

Bullies love to bully

The researchers from the University of Chicago used functional Magnetic Resonance Imaging (fMRI) scans of eight 16 to 18 year-old boys with aggressive conduct disorder and compared them to eight matched adolescents without conduct disorder.

9 Nov 2008

Brain scans show bullies may enjoy seeing others in pain

Unusually aggressive youth may actually enjoy inflicting pain on others, research using brain scans at the University of Chicago shows.

8 Nov 2008

Dermatitis management

Although the variety of substances that can cause contact dermatitis is almost limitless, it often can be effectively managed with the proper diagnosis and treatment according to investigators presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Seattle.

7 Nov 2008

Peck on the leg from a magpie leads to amputation

A new study has revealed that a peck on the leg from a pet magpie resulted in an elderly Australian woman losing her lower leg.

4 Nov 2008

Two different approaches used to correct clubfoot both bring positive outcomes for most children

Two non-surgical treatments most commonly used to correct the condition known as clubfoot have similarly high levels of success, according to a new study published in the November 2008 issue of The Journal of Bone and Joint Surgery.

4 Nov 2008

Re-regulating global finance with the poor in mind

For the poor, finance is always about much more than economics. In practical as well as philosophical terms it is a matter of basic human rights. As the dust begins to settle on the global financial crisis it is certain that all economies will suffer. For the rich, OECD states, stagnation or recessionary losses are predicted, and for the emerging (BRIC) economies of Brazil, Russia, India and China, growth will significantly slow. But it is in the poorest, least developed states that we will likely see the most dramatic effects, simply because they have less to lose.

27 Oct 2008

NanoVibronix receives FDA clearance for PainShield diathermy device

NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.

23 Oct 2008

Hand, foot and mouth disease in China kills 3 children and sickens over 100 others

In the latest health scare in China three children have died from hand, foot and mouth disease and another 110 are sick - this is China's second outbreak of the virus this year in young children.

20 Oct 2008

People with diabetes lose more than money

It is not about money. No amount of money will give back my limb" said a 65 years old woman with diabetes (name withheld on request) who underwent limb amputation at the Gandhi Memorial & Associated Hospitals (GM & AH).

7 Oct 2008

People 'touch wood' to impose order

New research suggests that the reason why people carry out rituals such as touching wood or wearing a 'lucky' item or some other behaviour, is because they are experiencing a loss of control in their lives.People ' touch wood' to impose order on chaos

6 Oct 2008

Guide to the virtual medical universe

Despite the weak dollar, a growing number of Americans are traveling overseas for less expensive medical care. But there's another way to become a so-called medical tourist, without a passport, luggage, or even leaving your house, notes the October 2008 issue of the Harvard Health Letter. All you need for this version of medical globe-trotting is a computer, an Internet connection, and some curiosity.

29 Sep 2008

Nanotherapeutics files INDA for NanoDOX hydrogel to treat type of diabetic ulcers

Nanotherapeutics announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX Hydrogel, a topical doxycycline hydrogel for chronic wounds.

4 Sep 2008

Height linked to risk of prostate cancer

A man's height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer, say Bristol researchers who conducted their own study on the connection and also reviewed 58 published studies.

3 Sep 2008